Himanshu Arvind Joshi

Suggest Changes
Learn More
This phase III clinical trial was conducted to evaluate the immunogenicity and safety of the single-dose and multi-dose formulations of a novel MMR vaccine (live, freeze-dried) developed by M/s(More)
  • 1